The US Food and Drug Administration’s Human Foods Program has published an updated guidance agenda outlining its priority focus areas for the remainder of 2026.
The agenda, released on 29 June 2026, identifies several key subjects the agency intends to address through forthcoming guidance documents aimed at the food and beverage industry.
Among the priority topics is caffeine content labelling in foods and beverages, reflecting growing regulatory scrutiny of stimulant levels in consumer products across the United States.
The agenda also highlights plans to issue questions and answers regarding the use of “healthy” claims, a subject that has long generated debate among food manufacturers and nutritional advocates alike.
Regulators are additionally planning to establish action levels for cadmium and inorganic arsenic in food products specifically designed for babies and young children, targeting heavy metal contamination risks.
The use of fruit juice and vegetable juice as colour additives in food is another area earmarked for guidance, as manufacturers increasingly seek natural alternatives to synthetic colouring agents.
Identity and safety information about new dietary ingredients also features prominently in the agenda, signalling continued attention to the fast-growing supplements and functional food sectors.
The programme further intends to release multiple guidance documents aimed at reducing both chemical and microbiological hazards across the broader food supply chain.
While guidance documents do not impose legally enforceable requirements, they represent FDA’s current thinking and interpretation on a specific topic that the industry can use as practical guidance.
The agency is inviting public input on the proposed topics through the federal government’s regulations portal, with comments accepted via Docket FDA-2022-D-2088 at www.regulations.gov.
Industry stakeholders, including food manufacturers, retailers, and consumer safety advocates, are encouraged to submit responses as the FDA moves forward with its regulatory planning process.
The breadth of the 2026 agenda reflects the Human Foods Program’s ongoing effort to modernise food safety standards and provide clearer direction to businesses operating in a rapidly evolving market.